By expenditures
| Name | Title | Type |
|---|---|---|
| Robert Tonkinson | Senior Vice President & Chief Financial Officer | Auditee |
| Andrea Spetrini | Partner/Principal, Healthcare Assurance | Auditee |
| Doug Davenport | SENIOR VICE PRESIDENT AND CFO | Auditee |
| Karen Fitzsimmons | National Healthcare Industry Co-leader | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 368028 | 2024 | 2025-09-26 | Bdo USA PC | $2.40M |
| 322835 | 2023 | 2024-09-30 | Bdo USA PC | $2.26M |
| 41715 | 2022 | 2023-10-01 | Bdo USA PC | $39.37M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 368028 | 2024 | 2025-09-26 | 1155732 | 2024-001 | Material Weakness | Yes | N |
| 368028 | 2024 | 2025-09-26 | 1155731 | 2024-001 | Material Weakness | Yes | N |
| 322835 | 2023 | 2024-09-30 | 1076352 | 2023-001 | Significant Deficiency | Yes | N |
| 322835 | 2023 | 2024-09-30 | 1076351 | 2023-001 | Significant Deficiency | Yes | N |
| 322835 | 2023 | 2024-09-30 | 499910 | 2023-001 | Significant Deficiency | Yes | N |
| 322835 | 2023 | 2024-09-30 | 499909 | 2023-001 | Significant Deficiency | Yes | N |
| 41715 | 2022 | 2023-10-01 | 627136 | 2022-002 | Significant Deficiency | - | A |
| 41715 | 2022 | 2023-10-01 | 627135 | 2022-001 | Significant Deficiency | - | N |
| 41715 | 2022 | 2023-10-01 | 627134 | 2022-001 | Significant Deficiency | - | N |
| 41715 | 2022 | 2023-10-01 | 50694 | 2022-002 | Significant Deficiency | - | A |
| 41715 | 2022 | 2023-10-01 | 50693 | 2022-001 | Significant Deficiency | - | N |
| 41715 | 2022 | 2023-10-01 | 50692 | 2022-001 | Significant Deficiency | - | N |